NCT01945047View on ClinicalTrials.gov

Action of Ketamine in Treatment-Resistant Depression

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Treatment-resistant Depression
Interventions
DRUG

Ketamine

Intravenous Bolus infusion Ketamine Hydrochloride 0.50 mg/mL over 40 minutes

DRUG

Midazolam

Bolus infusion of Midazolam Hydrochloride 1 mg/mL over 40 minutes

Trial Locations (1)

K1Z 7K4

Institute of Mental Health Research, Royal Ottawa Hospital, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

University of Ottawa

OTHER

NCT01945047 - Action of Ketamine in Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter